RV41 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fennec Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8.6 EUR 1.18% Market Closed

Market Cap: €235m

F	Fennec Pharmaceuticals Inc F:RV41	US
	Telefonica SA BMV:TEFN	ES
W	Wabash National Corp F:WA9	US
E	Everest Group Ltd DUS:ERE	BM
	Kirin Holdings Co Ltd F:KIR0	JP
	Global Education Communities Corp TSX:GEC	CA
P	Pioneer Natural Resources Co F:PNK	US
	Murray & Roberts Holdings Ltd F:LDYA	ZA
U	UniCredit SpA OTC:UNCRY	IT
K	Kinder Morgan Inc XMUN:2KD	US

Profitability Summary

Fennec Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

94% > 92%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-56%

Operating Margin is Increasing

-755% > -14%

Negative Net Margin

-22%

Negative 3Y Average Net Margin

-68%

Net Margin is Increasing

-810% > -22%

Negative Free Cash Flow Margin

-28%

Negative 3Y Average Free Cash Flow Margin

-43%

Free Cash Flow Margin is Increasing

-645% > -28%

Negative ROE

-66%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 327%

ROIC is Increasing

-32 427% > -29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.